These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17244124)

  • 1. Gene polymorphism association studies in dialysis: vascular access.
    Girndt M; Heine GH; Ulrich C; Köhler H;
    Semin Dial; 2007; 20(1):63-7. PubMed ID: 17244124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of genetic polymorphisms and hemodialysis vascular access thrombosis.
    Brophy DF; Bukaveckas BL; Ferreira-Gonzalez A; Archer KJ; Martin EJ; Gehr TW
    Hemodial Int; 2009 Jan; 13(1):19-26. PubMed ID: 19210273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of prothrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of congenital cardiac surgery.
    Ozbek N; Ataç FB; Yildirim SV; Verdi H; Yazici C; Yilmaz BT; Tokel NK
    Cardiol Young; 2005 Feb; 15(1):19-25. PubMed ID: 15831156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of PAI-1 4G/5G and ACE DD genotypes increases the risk of early-stage AVF thrombosis in hemodialysis patients.
    Güngör Y; Kayataş M; Yıldız G; Özdemir Ö; Candan F
    Ren Fail; 2011; 33(2):169-75. PubMed ID: 21332339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of thrombophilia in vascular access thrombosis among chronic hemodialysis patients in Tunisia.
    Fekih-Mrissa N; Klai S; Bafoun A; Nciri B; Hmida J; Gritli N
    Ther Apher Dial; 2011 Feb; 15(1):40-3. PubMed ID: 21272251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
    Hoppe B; Tolou F; Dörner T; Kiesewetter H; Salama A
    Thromb Haemost; 2006 Oct; 96(4):465-70. PubMed ID: 17003923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular access for hemodialysis.
    Santoro A; Canova C; Freyrie A; Mancini E
    J Nephrol; 2006; 19(3):259-64. PubMed ID: 16874684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombophilia and the risk for hemodialysis vascular access thrombosis.
    Knoll GA; Wells PS; Young D; Perkins SL; Pilkey RM; Clinch JJ; Rodger MA
    J Am Soc Nephrol; 2005 Apr; 16(4):1108-14. PubMed ID: 15728780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vascular access for dialysis in elderly: AVF versus permanent CVC].
    Brunori G; Bandera A; Valente F; Laudon A
    G Ital Nefrol; 2008; 25(6):614-8. PubMed ID: 19048553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some old drugs improve late primary patency rate of native arteriovenous fistulas in hemodialysis patients.
    Righetti M; Ferrario G; Serbelloni P; Milani S; Tommasi A
    Ann Vasc Surg; 2009; 23(4):491-7. PubMed ID: 18973987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [When native arteriovenous fistula is not possible: the permanent catheter is better].
    Coli' L; Cuna V; Capelli I; Kwin C; Donati G; La Manna G; Stefoni S
    G Ital Nefrol; 2009; 26(2):154-7. PubMed ID: 19382070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of angiotensin-converting enzyme and methylenetetrahydrofolate reductase gene polymorphisms as determinant risk factors for chronic allograft dysfunction.
    de Alvarenga MP; Pavarino-Bertelli EC; Abbud-Filho M; Ferreira-Baptista MA; Haddad R; Eberlin MN; Goloni-Bertollo EM
    Transplant Proc; 2007; 39(1):78-80. PubMed ID: 17275478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical and legal obligation to avoid long-term tunneled catheter access.
    Rehman R; Schmidt RJ; Moss AH
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):456-60. PubMed ID: 19158368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular access in patients treated with chronic hemodialysis for 30 years or more.
    Buturović-Ponikvar J; Persic V; Malovrh M; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):354-7. PubMed ID: 19695074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint.
    Roy-Chaudhury P; Sukhatme VP; Cheung AK
    J Am Soc Nephrol; 2006 Apr; 17(4):1112-27. PubMed ID: 16565259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case report of recurrent vascular access thrombosis in a hemodialysis patient reveals combined acquired and inherited thrombophilia.
    Eleftheriadis T; Antoniadi G; Akritidou A; Kasimatis E; Apostolidis G; Pashalidou S; Salmas M; Liakopoulos V; Barboutis K
    Ther Apher Dial; 2008 Apr; 12(2):190-2. PubMed ID: 18387172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary arteriovenous fistulas: converting prosthetic AV grafts to autogenous dialysis access.
    Slayden GC; Spergel L; Jennings WC
    Semin Dial; 2008; 21(5):474-82. PubMed ID: 18627564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular access for dialysis: recent lessons and new insights.
    Vazquez MA
    Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):116-21. PubMed ID: 19434049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular access-related thrombotic complications: research hypotheses and therapeutic strategies.
    Bruno S; Remuzzi G
    J Nephrol; 2006; 19(3):280-5. PubMed ID: 16874686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of genotype polymorphisms with vascular access patency in hemodialysis patients.
    Chen CF; Lin CC
    J Vasc Access; 2019 May; 20(1_suppl):24-30. PubMed ID: 29512407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.